← Back to Search
In Vitro Prevention Of Cell‐mediated Xeno‐graft Rejection Via The Fas/FasL‐pathway In CrmA‐transducted Porcine Kidney Cells
M. Fujino, X. Li, T. Suda, M. Hashimoto, K. Okabe, H. Yaginuma, K. Mikoshiba, L. Guo, T. Okuyama, S. Enosawa, H. Amemiya, T. Amano, S. Suzuki
Published 2001 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Abstract: Cell‐mediated cytotoxicity may be involved in delayed and/or chronic xenograft rejection in which apoptosis is induced in the grafted cells via the Fas/Fas‐ligand (FasL) and perforin/granzyme pathways. One barrier to the potential use of xeonogenic grafts for humans may be Fas/FasL‐mediated apoptosis, which would be blocked by the gene expression of cytokine response modifier A (CrmA), a cowpox virus gene product. The purpose of this study is to explore whether crmA is an effective candidate gene for inhibiting apoptosis in an in vitro model of xenograft rejection, using Fas‐expressing non‐primate cells cultured with a soluble recombinant human FasL (sFasL). A recombinant adenovirus vector expressing CrmA (AxCALNLCrmA) was successfully generated with a Cre‐mediated switching system. PK15 cells, derived from a porcine kidney and infected with AxCALNLCrmA and/or AxCANCre at a multiplicity of infection (MOI) ranging from 0.1 to 100, were cultured with human sFasL derived from KFL74.18, a human FasL‐overexpressed cell line. The gene‐expression level of the PK15 cells was confirmed by CrmA‐immune staining. Approximately 70% of the control PK15 cells showed induced apoptosis when cultured with sFasL. In contrast, the apoptosis was dramatically reduced in crmA‐gene‐transduced PK15 cells. The inhibitory effect of apoptosis increased with an increase in the infection dose of AxCANCre. In addition, the activity of caspases 3 and 8 was significantly inhibited in the crmA‐transduced cells. These results indicate that CrmA is an effective gene product for inhibiting Fas/FasL‐mediated apoptosis, which suggests the potential therapeutic use of its gene transduction to protect against graft damage due to delayed and/or chronic xenograft rejection.
This paper references
Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase.
Y. Kanegae (1995)
T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
D. Candinas (1996)
Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates
R. Chen (1999)
Mitochondria-dependent and -independent Regulation of Granzyme B–induced Apoptosis
G. MacDonald (1999)
CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ Tcells and Bcells
T LOUDOVARIS (1996)
surface death receptors
M ENARI (1998)
CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells.
T. Loudovaris (1996)
An atlas of serpin conformations.
J. Whisstock (1998)
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
M. Enari (1996)
Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.
M. Smyth (1996)
Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
Setsuko Sahara (1999)
Two CD95 (APO‐1/Fas) signaling pathways
C. Scaffidi (1998)
Xenogeneic skin graft rejection is especially dependent on CD4+ T cells
R. Pierson (1989)
Target Protease Specificity of the Viral Serpin CrmA
Q. Zhou (1997)
Involvement of an ICE-like protease in Fas-mediated apoptosis
M. Enari (1995)
Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
K. Yamada (1995)
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
H. Li (1998)
Bcl-2 protects Prevention of cell-mediated xenograft rejection 123 from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
V LACRONIQUE (1996)
Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28.
A. Murray (1994)
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Nancy A. Thornberry (1992)
Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
M. Miura (1993)
Prevention of vertebrate neuronal death by the crmA gene.
V. Gagliardini (1994)
Fas‐mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases
R. A. Jones (1998)
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
N. Boudreau (1995)
CrmA, a Poxvirus-encoded Serpin, Inhibits Cytotoxic T-lymphocyte-mediated Apoptosis (*)
M. Tewari (1995)
Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.
S. Srinivasula (1996)
Cellular rejection in discordant xenografts when hyperacute rejection is prevented: analysis using adoptive and passive transfer.
J. P. Fryer (1994)
Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses1
R. Lee (2000)
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).
D. Huang (1999)
Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice
V. Lacronique (1996)
; 393 : 396 )
Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.
S. C. Chow (1999)
Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
M. Smyth (1997)
death gene ced - 3
V GAGLIARDINI (1993)
A neural cell-type-specific expression system using recombinant adenovirus vectors.
M. Hashimoto (1996)
Delayed xenograft rejection.
W. Hancock (1997)
Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis*
X. Sun (1999)
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
C. Ray (1992)
Controlled Fas ligand gene expression by Cre/loxP-mediated switching system: high levels of FasL expression result in lethal hepatitis.
M. Fujino (1999)
T cells are necessary and critical for xenograft rejection in new concordant cardiac xenotransplant model.
M. Obatake (1999)
Blockade of CD28
RS LEE (2000)
Bid , a Bcl 2 interacting protein , mediates cytochrome c release from mitochondria in response to activation of
Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition.
T. Komiyama (1994)
Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system
T. Okuyama (1998)
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors
X. Luo (1998)
CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO‐1)‐transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
K. Smith (1996)
Immunology of xenograft rejection.
D. Sachs (1990)
The molecular mechanism of apoptosis induced by xenogeneic cytotoxicity
I. Fujiwara (1998)
Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.
D. Pickup (1986)
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
M. Enari (1998)
Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice.
C. F. Morris (1995)
CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway.
S. Yi (1999)
On/off switching Fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system.
M. Fujino (1999)
EVIDENCE THAT MULTIPLE DEFECTS IN CELL‐SURFACE MOLECULE INTERACTIONS ACROSS SPECIES DIFFERENCES ARE RESPONSIBLE FOR DIMINISHED XENOGENEIC T CELL RESPONSES1
R. D. Moses (1992)
Fas ligand in human serum
M. Tanaka (1996)
Human ICE/CED-3 protease nomenclature [letter
E. Alnemri (1996)
Granzyme B Is Inhibited by the Cowpox Virus Serpin Cytokine Response Modifier A(*)
L. T. Quan (1995)
Human ICE/CED-3 Protease Nomenclature
E. Alnemri (1996)
This paper is referenced by
Poxviruses and apoptosis: a time to die.
H. Everett (2002)
Proteinaceous cysteine protease inhibitors
G. Dubin (2004)
Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells).
M. Fujino (2002)
Catalytic RAG1 mutants obstruct V(D)J recombination in vitro and in vivo.
Tadashi Furusawa (2003)
Chondroprotective Effects of Hyaluronic Acid-Chitosan Nanoparticles Containing Plasmid DNA Encoding Cytokine Response Modifier A in a Rat Knee Osteoarthritis Model
Pang-Hu Zhou (2018)
Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide.
Pervinder Sagoo (2004)
Apoptosis and plastic surgery.
B. Gastman (2003)
Inducible liver injury in the transgenic rat by expressing liver-specific suicide gene.
M. Kawasaki (2003)
Inhibition of allogeneic T‐cell responses by dendritic cells expressing transduced indoleamine 2,3‐dioxygenase
N. Funeshima (2005)
CrmA gene expression protects mice against concanavalin-A-induced hepatitis by inhibiting IL-18 secretion and hepatocyte apoptosis
M. Fujino (2003)
Microbial inhibitors of cysteine proteases
Mateusz Kedzior (2016)